Which oncology KOLs should we prioritize for a variety of launch planning use cases ?
The oncology team at a large pharmaceutical company was gearing up for multiple prostate cancer drug launches over the next 5 years. They wanted to establish their thought leadership and reputation in the market through a robust KOL strategy, that included KOLs for both traditional and emerging use cases like digital.
Finding the right influence for this purpose was different than their normal projects because:
They needed a new analytics approach to build a robust directory of KOLs for multiple use cases:
Best fit KOLs were identified, scored and categorized via clinical, social, and academic influence analysis
The launch planning team partnered with DRG to build a custom grouping and scoring model to match KOLs to their multiple use cases.
DRG built a team of data scientists, oncology experts, market consultants, and digital specialists to create a robust scoring criteria based on a variety of data sources, including DRG claims data, publications, social influence and peer-to-peer recommendation.
After data extraction, priority HCPs were identified using a model to weight the relative importance of each metric for each KOL application. Additionally, key KOLs were profiled individually.
Through this integrated analysis and scoring model, we were able to help the client identify the best fit physicians for each unique use case, and their level of importance now, and potentially in the future.
DRG armed the client with:
The client commented that many of the influential KOLs identified through the multi-data source analysis were unknown to them, and they could not have found them through traditional KOL analysis alone.
Need help sizing your markets?
When you are faced with tough business questions, DRG analytics specialists are here to help you define the best path forward.
Read our latest executive briefing: Advanced Targeting: Activating Networks of Influence